The NHS is now offering an injectable form of Keytruda (pembrolizumab) that can be administered in under two minutes, dramatically reducing treatment times from over an hour. This advancement, following last year's introduction of injectable nivolumab, promises to save hundreds of thousands of hours annually while cutting costs and improving patient care across cancer treatment services.

The Review also sets out recommendations about how to address shortcomings identified in the 2012 Regulations.

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country.

Earlier today, UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorization to Vertex Pharmaceuticals and CRISPR Therapeutics...

The UK Environment Secretary Michael Gove announced on June 25, 2019 that food labeling laws will be changed to introduce full ingredient labelling (including allergens) for foods which are packed for direct sale.

Zentiva, a Portuguese generics company, sought and was granted marketing authorisation for a generic form of Boehringer Ingelheim's idiopathic pulmonary fibrosis drug Ofev (nintedanib) in August 2024

Global consumer and retail dealmaking saw a decisive shift toward large‑cap transactions in Q4 2025. Total deal value rose to £88bn, up 52% quarter‑on‑quarter...

Alvotech recently submitted a Citizen Petition to the FDA requesting that the agency refuse to license any ustekinumab biosimilar as interchangeable with STELARA if it is manufactured using a Chinese hamster ovary ("CHO")...

Just about everyone I know, myself included, loves chocolate, and it's often a feature in our office. The history of this universally popular food goes back centuries, and has gone from being introduced to Europe as food...

I have previously reported on the issues we face regarding increased antimicrobial resistance and limited new antibiotics being developed.

Antimicrobial resistance, or AMR, is one of the major current health concerns. Resistant strains which have emerged recently include gonorrhoea, tuberculosis, MRSA, and even the bubonic plague.

On June 2, 2025, the United Kingdom (UK) Department for Environment, Food & Rural Affairs (Defra) requested comment on...

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs.

Between 2012 and 2015 the firm acted for a pharmacist client which wished to object to the intended relocation of a new competitor pharmacy within a short distance from its own retail pharmacy.

Sustainable packaging is a hot topic. Sustainable alternatives to conventional plastic packaging exist, and generally consist of biodegradable materials which are either derived from renewable natural sources...

Welcome to our new blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink sector.

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink sector.

The identification of specific sub-groups of patients to treat with a known drug, even if said patients may have been treated before with the drug...

Millions of people worldwide suffer from pain that is perceived to be in an area of the body that is paradoxically no longer (or never was) attached to the body.

In the recent decision Generics v AstraZeneca, the UK Court of Appeal confirmed that the UK's approach to ‘plausibility' remains unchanged despite the EPO Enlarged Board of Appeal decision G2/21.